Started in 1978, apex laboratories has been under the able leadership of Mr.S.S.Vanangamudi who is heading the company as the Chairman & Managing Director.
The company is a pioneer in the introduction of Zinc based formulations in India and continues to be the brand leader in the Multivitamin Mineral Supplements segment. The company's growth is powered by its focus on manufacture and supply of quality products, formidable sales & marketing strength, 100% ethical promotion, growing market acceptance of the products and continued patronage by the medical fraternity.
With humble beginnings and 4 decades of growth history, the company today boasts of a formidable people strength of over 2500, strong manufacturing capability of international standards, continuous technology improvement, all-India market presence, excellent distribution network and successful foray into herbal products. The company is ranked among the top 50 pharmaceutical companies in India and is also among the fastest growing business organization.
With a range of products in various segments, apex is proud of quite a few brand leaders in India, The company has recorded stable growth over the years and has registered steep growth in the last 15 years. The company aims to achieve INR 1000 Crores (USD 133 million) by 2025, by leveraging our manufacturing strength, increased presence in overseas markets, entry into regulated markets countries, innovative product launches and focus on R & D for developing innovative products to the global market.
I bring warm greetings from apex.
The last 4 decades have been an immensely gratifying experience. With very humble beginnings, today apex has become a significant player in the Indian pharmaceutical industry. We have evolved as a formidable organization with focus on quality products, strong customer focus, innovation and investment in intellectual property. We have established our leadership in the market by leveraging these strengths.
The company’s manufacturing capability is built and maintained at global standards with continuous technology improvement. Built to international specifications, we will be able to produce and supply products to the global market in addition to our existing presence in Asia and Africa and some regulated countries like UK, Europe and Canada.
Our company's ambitious plans for the future will be fuelled by the 4 growth engines namely - leveraging its manufacturing strength, increased presence in overseas markets including regulated markets countries, new product launches and increased focus on Research & Development for innovation and building Intellectual Property.
Our successful sales & marketing track record should make us an attractive proposition for multinational pharma companies looking to introduce their products in India.
With renewed and strategic focus on innovation, the company could develop many innovative products with our exclusive R&D Center, a DSIR approved facility. With a strong team of qualified scientists, the company could develop and obtain patent for over 100 products.
We will continue to be a value driven organization with commitment to contribute to the society by nurturing a vibrant business organization with a human face, known for its quality of products, customer focus, people-oriented management and doing business with conscience.
Leveraging our innate strength and with the new initiatives, I am sure we will achieve its short term and long term business goals to be among the global leaders in pharmaceutical space in the foreseeable future.
The company strives to become one of the leading players in pharmaceutical industry in India and the global market place, with significant contribution to the society with quality products at affordable cost, thereby becoming a household name in healthcare.
Sustaining brand leadership in its product segments and achieving brand equity in its product segments across the globe. Achievement of business turnover of USD 133 million (INR 1000 Crores) by 2025.
To contribute to the society by nurturing a vibrant business organization with a human face, known for its quality of products, customer focus, people-oriented management and doing business with conscience.
During the first half of the 20th century, researchers discovered that zinc is essential for the normal growth and survival of plants and animals. Clear evidence of human zinc deficiency began to emerge during the 1960s, when Dr Ananda Prasad first reported cases of dwarfism and delayed sexual maturity among Middle Eastern adolescents. Since then, many researchers working in different areas of the world have found that zinc supplementation increases growth among stunted children and reduces the prevalence of common childhood infections, such as diarrhea and pneumonia.
Zinc is essential for human health. It is vital for many biological functions such as disease resistance, wound healing, digestion, reproduction, physical growth and diabetes control. The "World Health Organization's World Health Report 2002" estimated that one-third (33%) of the world's population is at risk of inadequate zinc intakes.
apex pioneered the introduction of zinc-based formulations into the Indian market. The company's flagship brand Zincovit is the brand leader in its segment in India and has established our identity as 'The Zinc People' in the Indian and the international markets.